Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-casd-3_17-cv-01466/USCOURTS-casd-3_17-cv-01466-1/pdf.json

Nature of Suit Code: 190
Nature of Suit: Other Contract Actions
Cause of Action: 28:1332fr Diversity-Fraud

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF CALIFORNIA

EVEREST BIOSYNTHESIS GROUP,

LLC, dba NATURAL PLANT

EXTRACTS,

Plaintiff,

CASE NO. 17cv1466 JM(BGS)

ORDER REQUESTING STATUS

REPORT

v.

BIOSYNTHESIS PHARMA GROUP

LIMITED; BIOSYNTHESIS

PHARMA LTD; JAYTEE

BIOSCIENCES, LTD; TRIGAL

PHARMA LTD; IEFENBACHER API

GMBH; HANKANG BIO-TECH CO.;

BSPG LABORATORIES LTD; SPG

AUSTRIA GMBH; and MICHAEL

STEPHENSON,

Defendants.

On January 8, 2018, the court granted Defendants’ motion to compel arbitration

of the claims asserted by Plaintiff Everest Biosynthesis Group, dba Natural Plant

Extract, and stayed the action (the “Order”). The court also requested the partiesto file

a joint status report on the status of the arbitration proceeding by June 1, 2018. 

Plaintiff timely complied with the court’s Order and filed a status report. (ECF 11).

Plaintiff informed the court that counsel has been retained in Hong Kong and that

conclusion of the arbitration proceeding is anticipated by December 2018. 

/ / /

/ / /

- 1 - 17cv1466

Case 3:17-cv-01466-JM-BGS Document 12 Filed 06/06/18 PageID.<pageID> Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

The parties are instructed to file another joint status report on the status of the

arbitration proceeding by December 1, 2018.

IT IS SO ORDERED.

DATED: June 6, 2018

 Hon. Jeffrey T. Miller

 United States District Judge

cc: All parties

- 2 - 17cv1466

Case 3:17-cv-01466-JM-BGS Document 12 Filed 06/06/18 PageID.<pageID> Page 2 of 2